83 related articles for article (PubMed ID: 1448660)
1. [Chromosome abnormalities and adenine metabolism in human glial tumors].
Bardot V; Dutrillaux AM; Luccioni C; Poisson M; Delattre JY; Vega F; Dutrillaux B
Rev Neurol (Paris); 1992; 148(6-7):408-16. PubMed ID: 1448660
[TBL] [Abstract][Full Text] [Related]
2. Purine and pyrimidine metabolism in human gliomas: relation to chromosomal aberrations.
Bardot V; Dutrillaux AM; Delattre JY; Vega F; Poisson M; Dutrillaux B; Luccioni C
Br J Cancer; 1994 Aug; 70(2):212-8. PubMed ID: 8054268
[TBL] [Abstract][Full Text] [Related]
3. Molecular analysis of deletions of the short arm of chromosome 9 in human gliomas.
Olopade OI; Jenkins RB; Ransom DT; Malik K; Pomykala H; Nobori T; Cowan JM; Rowley JD; Diaz MO
Cancer Res; 1992 May; 52(9):2523-9. PubMed ID: 1568221
[TBL] [Abstract][Full Text] [Related]
4. DNA content and chromosomal composition of malignant human gliomas.
Bigner SH; Bjerkvig R; Laerum OD
Neurol Clin; 1985 Nov; 3(4):769-84. PubMed ID: 3001489
[TBL] [Abstract][Full Text] [Related]
5. [Targeting the gene of glucose metabolism for the treatment of advanced gliomas].
Oudard S; Miccoli L; Dutrillaux B; Poupon MF
Bull Cancer; 1998 Jul; 85(7):622-6. PubMed ID: 9752269
[TBL] [Abstract][Full Text] [Related]
6. A methylthioadenosine phosphorylase (MTAP) fusion transcript identifies a new gene on chromosome 9p21 that is frequently deleted in cancer.
Schmid M; Sen M; Rosenbach MD; Carrera CJ; Friedman H; Carson DA
Oncogene; 2000 Nov; 19(50):5747-54. PubMed ID: 11126361
[TBL] [Abstract][Full Text] [Related]
7. Fine mapping of a region of common deletion on chromosome arm 10p in human glioma.
Voesten AM; Bijleveld EH; Westerveld A; Hulsebos TJ
Genes Chromosomes Cancer; 1997 Oct; 20(2):167-72. PubMed ID: 9331567
[TBL] [Abstract][Full Text] [Related]
8. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
[TBL] [Abstract][Full Text] [Related]
9. Specific chromosomal abnormalities in malignant human gliomas.
Bigner SH; Mark J; Burger PC; Mahaley MS; Bullard DE; Muhlbaier LH; Bigner DD
Cancer Res; 1988 Jan; 48(2):405-11. PubMed ID: 3335011
[TBL] [Abstract][Full Text] [Related]
10. [Nucleotide metabolism in human glioma: comparative study of primary tumors, grafted tumors on nude mice and cell cultures].
Bardot V; Dutrillaux AM; Reillaudou M; Dutrillaux B; Luccioni C
Bull Cancer; 1994 Apr; 81(4):297-302. PubMed ID: 7703546
[TBL] [Abstract][Full Text] [Related]
11. Loss of heterozygosity of chromosome 10p in human gliomas.
Kimmelman AC; Ross DA; Liang BC
Genomics; 1996 Jun; 34(2):250-4. PubMed ID: 8661060
[TBL] [Abstract][Full Text] [Related]
12. Loss of genetic material is more common than gain in acute myeloid leukemia with complex aberrant karyotype: a detailed analysis of 125 cases using conventional chromosome analysis and fluorescence in situ hybridization including 24-color FISH.
Schoch C; Haferlach T; Bursch S; Gerstner D; Schnittger S; Dugas M; Kern W; Löffler H; Hiddemann W
Genes Chromosomes Cancer; 2002 Sep; 35(1):20-9. PubMed ID: 12203786
[TBL] [Abstract][Full Text] [Related]
13. A role for telomeric and centromeric instability in the progression of chromosome aberrations in meningioma patients.
Sawyer JR; Husain M; Pravdenkova S; Krisht A; Al-Mefty O
Cancer; 2000 Jan; 88(2):440-53. PubMed ID: 10640979
[TBL] [Abstract][Full Text] [Related]
14. Comparative genomic hybridization of human malignant gliomas reveals multiple amplification sites and nonrandom chromosomal gains and losses.
Schröck E; Thiel G; Lozanova T; du Manoir S; Meffert MC; Jauch A; Speicher MR; Nürnberg P; Vogel S; Jänisch W
Am J Pathol; 1994 Jun; 144(6):1203-18. PubMed ID: 8203461
[TBL] [Abstract][Full Text] [Related]
15. Chromosome 10 deletion mapping in human gliomas: a common deletion region in 10q25.
Rasheed BK; McLendon RE; Friedman HS; Friedman AH; Fuchs HE; Bigner DD; Bigner SH
Oncogene; 1995 Jun; 10(11):2243-6. PubMed ID: 7784070
[TBL] [Abstract][Full Text] [Related]
16. Two types of chromosome 1p losses with opposite significance in gliomas.
Idbaih A; Marie Y; Pierron G; Brennetot C; Hoang-Xuan K; Kujas M; Mokhtari K; Sanson M; Lejeune J; Aurias A; Delattre O; Delattre JY
Ann Neurol; 2005 Sep; 58(3):483-7. PubMed ID: 16130103
[TBL] [Abstract][Full Text] [Related]
17. Nucleotide-metabolism and chromosome alterations in human-malignant melanoma xenografts.
Bardot V; Luccioni C; Dutrillaux A; Blancho D; Beaumatin J; Dutrillaux B
Int J Oncol; 1995 Sep; 7(3):547-54. PubMed ID: 21552873
[TBL] [Abstract][Full Text] [Related]
18. Clonal genomic alterations in glioma malignancy stages.
James CD; Carlbom E; Dumanski JP; Hansen M; Nordenskjold M; Collins VP; Cavenee WK
Cancer Res; 1988 Oct; 48(19):5546-51. PubMed ID: 2901288
[TBL] [Abstract][Full Text] [Related]
19. p53 mutation, EGFR gene amplification and loss of heterozygosity on chromosome 10, 17 p in human gliomas.
Jin W; Xu X; Yang T; Hua Z
Chin Med J (Engl); 2000 Jul; 113(7):662-6. PubMed ID: 11776043
[TBL] [Abstract][Full Text] [Related]
20. Recurrent gain of chromosome arm 7q in low-grade astrocytic tumors studied by comparative genomic hybridization.
Schröck E; Blume C; Meffert MC; du Manoir S; Bersch W; Kiessling M; Lozanowa T; Thiel G; Witkowski R; Ried T; Cremer T
Genes Chromosomes Cancer; 1996 Apr; 15(4):199-205. PubMed ID: 8703845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
